Latest1 information on COVID-19
©2022 Stanford Medicine
Not Recruiting
Trial ID: NCT00005774
Early Surfactant Followed by Nasal CPAP to Reduce the Use of Mechanical Ventilation Without Additional Morbidity in Infants 1250- 2000 Grams With RDS
Inclusion Criteria:
- Infants born at 1,250-2g000 grams birth weight
- <12 hours of age
- Clinical and radiographic diagnosis of respiratory distress syndrome (RDS)
- Receiving supplemental oxygen with head-hood Fi02 of 0.35 to 0.50 or CPAP Fi02 of 0.25
to 0.50 to maintain oxygen saturation less than 90 percent and more than 96 percent
Exclusion Criteria:
- Receiving mechanical ventilation
- Air leak
- Pulmonary hemorrhage
- Major congenital anomaly
- Congenital non-bacterial infection
- Parental refusal of consent
- Refusal of attending neonatologist
drug: Early surfactant
drug: Standard practice
Not Recruiting
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305